Writing for GBH, lecturer Malia Lazu explores how to build racial equity into the innovation economy. “Without centering the value of Black contributions to our economy,” writes Lazu, “economic equity in our country will be nothing more than a good intention.”
Nobull, a direct-to-consumer fitness brand co-founded by alumnus Marcus Wilson MBA ’04, is releasing a line of apparel designed by Boston teens, as part of an effort with Artists for Humanity to help connect under-resourced teens with opportunities in arts and design, reports Anissa Gardizy for The Boston Globe.
Fast Company reporter Rachel Raczka spotlights Season Three, a startup founded by three MIT graduates aimed at designing a shoe that fits “practical parameters but performed like a stylish, everyday sneaker that you wouldn’t dread wearing.”
Financial Times reporter Michael Pooler highlights MIT startup Boston Metals, which has devised “a technology for making brand-new steel without emissions using electricity.”
Writing for The Boston Globe, AgeLab Director Joseph Coughlin and Research Associate Luke Yoquinto explore how Greater Boston could serve as an innovation hub for aging populations. “By making groundbreaking creativity and inventiveness for older adults both seen and felt, Greater Boston and New England will be able to offer the world a new vision of old age,” they write.
Bloomberg Businessweek reporter Peter Coy spotlights how the loss of several people close to Prof. Andrew Lo inspired him to explore how the field of finance could help advance treatments for orphan diseases. “Finance plays a huge role, sometimes way too big a role, in how drugs get developed,” says Lo. Fixing the financing model, could have a “tremendous, tremendous impact on health care.”
Forbes contributor Elizabeth Brownfield spotlights Lovebox, an MIT startup, which has created an electronic love note messenger. “When the heart on the outside of the wooden box spins, it means a love note has arrived. When the lid is lifted, a message is displayed on the screen,” Brownfield explains.
Boston Globe reporter Hiawatha Bray spotlights Pison Technology, an MIT startup that has developed a new gesture control system that can be used to manipulate “digital devices by intercepting the electronic traffic between our hands and our brains, and translating them into commands the machines can understand.”
Quartz reporter Michael Coren spotlights a study by Prof. Fiona Murray examining the effectiveness of prizes and competitions in finding solutions for real-world problems. “If you’re not quite sure what the solution should look like and you want to focus attention on something,” says Murray, “then you actually don’t mind the fact that lots of people are turning up and coming with novel ideas.”
Writing for The New Yorker, Sheelah Kolhatkar spotlights Biobot Analytics, an MIT startup that is studying sewage for the purpose of tracking diseases and the spread of Covid-19. “It’s about our health and well-being in general,” says Biobot co-founder and president Newsha Ghaeli. “It’s about understanding nutrition disparities in communities, understanding stress levels, pervasive infectious diseases like influenza or Zika virus.”
Forbes contributor Adi Gaskell spotlights how the MIT Task Force on the Work of the Future recently released a comprehensive report examining the future of work. Gaskell writes that the Task Force's report emphasizes the “pressing issues of our time as one of improving the quality of jobs to ensure that prosperity is shared across the economy.”
Boston Globe reporter Jon Chesto writes that MIT, Harvard, several research hospitals and life-sciences companies have selected a site for a new biologics manufacturing and innovation center. The project is aimed at expediting “discoveries for biotech treatments in university labs by allowing researchers to bypass the long waits that are common at contract manufacturers,” writesChesto.
New York Times reporter Steve Lohr spotlights Inrupt, an MIT startup founded by Prof. Tim Berners-Lee, which is aimed at providing people more control over their personal data. “Tim has become increasingly concerned as power in the digital world is weighted against the individual,” explains Daniel Weitzner, a principal research scientist at CSAIL.
TechCrunch reporter Jonathan Shieber spotlights Senti Biosciences, an MIT startup, which is developing cancer therapies using a new programmable biology platform. “The company’s technology uses new computational biological techniques to manufacture cell and gene therapies that can more precisely target specific cells in the body,” Shieber explains.
Fortune reporters Jeremy Kahn and Jonathan Vanian highlight MIT startup Macro-Eyes, which is focused on using AI to improve health care in low and middle-income countries.